Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0032991 | protein-containing complex | 1 | 11 |
| GO:0034708 | methyltransferase complex | 4 | 11 |
| GO:0035097 | histone methyltransferase complex | 3 | 11 |
| GO:0044666 | MLL3/4 complex | 4 | 11 |
| GO:0048188 | Set1C/COMPASS complex | 4 | 11 |
| GO:0140513 | nuclear protein-containing complex | 2 | 11 |
| GO:1902494 | catalytic complex | 2 | 11 |
| GO:1990234 | transferase complex | 3 | 11 |
| GO:0005930 | axoneme | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HTN6
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006479 | protein methylation | 4 | 1 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
| GO:0008152 | metabolic process | 1 | 1 |
| GO:0008213 | protein alkylation | 5 | 1 |
| GO:0009987 | cellular process | 1 | 1 |
| GO:0016570 | histone modification | 5 | 1 |
| GO:0016571 | histone methylation | 5 | 1 |
| GO:0018022 | peptidyl-lysine methylation | 5 | 1 |
| GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
| GO:0018205 | peptidyl-lysine modification | 6 | 1 |
| GO:0019538 | protein metabolic process | 3 | 1 |
| GO:0032259 | methylation | 2 | 1 |
| GO:0034968 | histone lysine methylation | 6 | 1 |
| GO:0036211 | protein modification process | 4 | 1 |
| GO:0043170 | macromolecule metabolic process | 3 | 1 |
| GO:0043412 | macromolecule modification | 4 | 1 |
| GO:0043414 | macromolecule methylation | 3 | 1 |
| GO:0044237 | cellular metabolic process | 2 | 1 |
| GO:0044238 | primary metabolic process | 2 | 1 |
| GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
| GO:0051568 | histone H3-K4 methylation | 7 | 1 |
| GO:0071704 | organic substance metabolic process | 2 | 1 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 139 | 143 | PF00656 | 0.657 |
| CLV_C14_Caspase3-7 | 317 | 321 | PF00656 | 0.612 |
| CLV_C14_Caspase3-7 | 329 | 333 | PF00656 | 0.700 |
| CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.434 |
| CLV_NRD_NRD_1 | 362 | 364 | PF00675 | 0.364 |
| CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.490 |
| CLV_NRD_NRD_1 | 537 | 539 | PF00675 | 0.477 |
| CLV_NRD_NRD_1 | 54 | 56 | PF00675 | 0.470 |
| CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.452 |
| CLV_PCSK_FUR_1 | 535 | 539 | PF00082 | 0.523 |
| CLV_PCSK_FUR_1 | 91 | 95 | PF00082 | 0.483 |
| CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.457 |
| CLV_PCSK_KEX2_1 | 362 | 364 | PF00082 | 0.364 |
| CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.521 |
| CLV_PCSK_KEX2_1 | 537 | 539 | PF00082 | 0.535 |
| CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.583 |
| CLV_PCSK_PC1ET2_1 | 93 | 95 | PF00082 | 0.551 |
| CLV_PCSK_PC7_1 | 89 | 95 | PF00082 | 0.557 |
| CLV_PCSK_SKI1_1 | 162 | 166 | PF00082 | 0.399 |
| CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.323 |
| DEG_Kelch_Keap1_1 | 502 | 507 | PF01344 | 0.630 |
| DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.514 |
| DEG_SCF_FBW7_1 | 268 | 275 | PF00400 | 0.493 |
| DOC_CYCLIN_RxL_1 | 166 | 173 | PF00134 | 0.518 |
| DOC_MAPK_gen_1 | 166 | 174 | PF00069 | 0.347 |
| DOC_MAPK_MEF2A_6 | 473 | 480 | PF00069 | 0.593 |
| DOC_MAPK_NFAT4_5 | 473 | 481 | PF00069 | 0.599 |
| DOC_PP1_RVXF_1 | 254 | 261 | PF00149 | 0.365 |
| DOC_PP2B_LxvP_1 | 172 | 175 | PF13499 | 0.316 |
| DOC_PP4_FxxP_1 | 353 | 356 | PF00568 | 0.559 |
| DOC_USP7_MATH_1 | 24 | 28 | PF00917 | 0.458 |
| DOC_USP7_MATH_1 | 274 | 278 | PF00917 | 0.504 |
| DOC_USP7_MATH_1 | 299 | 303 | PF00917 | 0.389 |
| DOC_WW_Pin1_4 | 228 | 233 | PF00397 | 0.655 |
| DOC_WW_Pin1_4 | 268 | 273 | PF00397 | 0.369 |
| LIG_14-3-3_CanoR_1 | 169 | 175 | PF00244 | 0.476 |
| LIG_14-3-3_CanoR_1 | 454 | 462 | PF00244 | 0.351 |
| LIG_BIR_III_4 | 509 | 513 | PF00653 | 0.491 |
| LIG_BRCT_BRCA1_1 | 349 | 353 | PF00533 | 0.652 |
| LIG_eIF4E_1 | 32 | 38 | PF01652 | 0.458 |
| LIG_FHA_1 | 356 | 362 | PF00498 | 0.507 |
| LIG_FHA_1 | 368 | 374 | PF00498 | 0.480 |
| LIG_FHA_1 | 503 | 509 | PF00498 | 0.619 |
| LIG_FHA_2 | 320 | 326 | PF00498 | 0.611 |
| LIG_FHA_2 | 340 | 346 | PF00498 | 0.558 |
| LIG_FHA_2 | 413 | 419 | PF00498 | 0.610 |
| LIG_FHA_2 | 480 | 486 | PF00498 | 0.640 |
| LIG_GBD_Chelix_1 | 33 | 41 | PF00786 | 0.258 |
| LIG_LIR_Apic_2 | 350 | 356 | PF02991 | 0.597 |
| LIG_LIR_Gen_1 | 31 | 38 | PF02991 | 0.458 |
| LIG_LIR_Gen_1 | 447 | 458 | PF02991 | 0.389 |
| LIG_LIR_Gen_1 | 481 | 491 | PF02991 | 0.624 |
| LIG_LIR_Nem_3 | 31 | 35 | PF02991 | 0.458 |
| LIG_LIR_Nem_3 | 447 | 453 | PF02991 | 0.387 |
| LIG_LIR_Nem_3 | 481 | 486 | PF02991 | 0.636 |
| LIG_MYND_1 | 228 | 232 | PF01753 | 0.655 |
| LIG_NRBOX | 262 | 268 | PF00104 | 0.435 |
| LIG_REV1ctd_RIR_1 | 162 | 170 | PF16727 | 0.471 |
| LIG_RPA_C_Fungi | 49 | 61 | PF08784 | 0.494 |
| LIG_SH2_CRK | 450 | 454 | PF00017 | 0.333 |
| LIG_SH2_NCK_1 | 104 | 108 | PF00017 | 0.432 |
| LIG_SH2_STAP1 | 387 | 391 | PF00017 | 0.569 |
| LIG_SH2_STAP1 | 543 | 547 | PF00017 | 0.536 |
| LIG_SH2_STAT5 | 254 | 257 | PF00017 | 0.364 |
| LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.284 |
| LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.302 |
| LIG_SH2_STAT5 | 387 | 390 | PF00017 | 0.499 |
| LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.302 |
| LIG_SH3_3 | 23 | 29 | PF00018 | 0.302 |
| LIG_SH3_3 | 331 | 337 | PF00018 | 0.764 |
| LIG_TRAF2_1 | 149 | 152 | PF00917 | 0.550 |
| LIG_TRAF2_1 | 208 | 211 | PF00917 | 0.490 |
| LIG_TRAF2_1 | 343 | 346 | PF00917 | 0.661 |
| LIG_TRAF2_1 | 557 | 560 | PF00917 | 0.681 |
| LIG_TRAF2_1 | 95 | 98 | PF00917 | 0.444 |
| LIG_TYR_ITIM | 263 | 268 | PF00017 | 0.399 |
| LIG_TYR_ITIM | 448 | 453 | PF00017 | 0.376 |
| LIG_UBA3_1 | 171 | 176 | PF00899 | 0.374 |
| LIG_WRC_WIRS_1 | 480 | 485 | PF05994 | 0.587 |
| MOD_CDK_SPK_2 | 268 | 273 | PF00069 | 0.369 |
| MOD_CK1_1 | 222 | 228 | PF00069 | 0.728 |
| MOD_CK2_1 | 273 | 279 | PF00069 | 0.464 |
| MOD_CK2_1 | 339 | 345 | PF00069 | 0.748 |
| MOD_CK2_1 | 479 | 485 | PF00069 | 0.575 |
| MOD_CK2_1 | 554 | 560 | PF00069 | 0.624 |
| MOD_GlcNHglycan | 142 | 145 | PF01048 | 0.663 |
| MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.507 |
| MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.302 |
| MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.618 |
| MOD_GlcNHglycan | 276 | 279 | PF01048 | 0.527 |
| MOD_GlcNHglycan | 342 | 345 | PF01048 | 0.721 |
| MOD_GlcNHglycan | 456 | 459 | PF01048 | 0.345 |
| MOD_GlcNHglycan | 555 | 559 | PF01048 | 0.578 |
| MOD_GSK3_1 | 136 | 143 | PF00069 | 0.703 |
| MOD_GSK3_1 | 170 | 177 | PF00069 | 0.492 |
| MOD_GSK3_1 | 20 | 27 | PF00069 | 0.432 |
| MOD_GSK3_1 | 215 | 222 | PF00069 | 0.566 |
| MOD_GSK3_1 | 268 | 275 | PF00069 | 0.387 |
| MOD_N-GLC_1 | 268 | 273 | PF02516 | 0.495 |
| MOD_N-GLC_1 | 339 | 344 | PF02516 | 0.563 |
| MOD_NEK2_1 | 170 | 175 | PF00069 | 0.435 |
| MOD_NEK2_1 | 318 | 323 | PF00069 | 0.571 |
| MOD_PIKK_1 | 436 | 442 | PF00454 | 0.447 |
| MOD_PKA_2 | 140 | 146 | PF00069 | 0.668 |
| MOD_PKA_2 | 239 | 245 | PF00069 | 0.614 |
| MOD_Plk_1 | 197 | 203 | PF00069 | 0.524 |
| MOD_Plk_2-3 | 385 | 391 | PF00069 | 0.569 |
| MOD_Plk_4 | 285 | 291 | PF00069 | 0.499 |
| MOD_Plk_4 | 444 | 450 | PF00069 | 0.391 |
| MOD_ProDKin_1 | 228 | 234 | PF00069 | 0.650 |
| MOD_ProDKin_1 | 268 | 274 | PF00069 | 0.371 |
| MOD_SUMO_for_1 | 121 | 124 | PF00179 | 0.530 |
| MOD_SUMO_for_1 | 182 | 185 | PF00179 | 0.381 |
| MOD_SUMO_for_1 | 309 | 312 | PF00179 | 0.513 |
| MOD_SUMO_rev_2 | 43 | 48 | PF00179 | 0.551 |
| TRG_DiLeu_BaEn_1 | 110 | 115 | PF01217 | 0.405 |
| TRG_DiLeu_BaEn_4 | 503 | 509 | PF01217 | 0.670 |
| TRG_ENDOCYTIC_2 | 257 | 260 | PF00928 | 0.318 |
| TRG_ENDOCYTIC_2 | 265 | 268 | PF00928 | 0.331 |
| TRG_ENDOCYTIC_2 | 32 | 35 | PF00928 | 0.302 |
| TRG_ENDOCYTIC_2 | 450 | 453 | PF00928 | 0.328 |
| TRG_ER_diArg_1 | 192 | 195 | PF00400 | 0.543 |
| TRG_ER_diArg_1 | 361 | 363 | PF00400 | 0.371 |
| TRG_ER_diArg_1 | 53 | 55 | PF00400 | 0.588 |
| TRG_ER_diArg_1 | 537 | 540 | PF00400 | 0.554 |
| TRG_NLS_MonoCore_2 | 90 | 95 | PF00514 | 0.375 |
| TRG_NLS_MonoExtC_3 | 91 | 97 | PF00514 | 0.453 |
| TRG_NLS_MonoExtN_4 | 89 | 96 | PF00514 | 0.453 |
| TRG_Pf-PMV_PEXEL_1 | 68 | 72 | PF00026 | 0.439 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P3H1 | Leptomonas seymouri | 63% | 97% |
| A0A1X0NQN0 | Trypanosomatidae | 45% | 93% |
| A0A3S7WQC3 | Leishmania donovani | 100% | 100% |
| A0A422NJV4 | Trypanosoma rangeli | 39% | 100% |
| A4H5E1 | Leishmania braziliensis | 82% | 100% |
| C9ZPD6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
| E9AMH0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
| Q4QI73 | Leishmania major | 94% | 100% |
| V5BR17 | Trypanosoma cruzi | 40% | 100% |